Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerae O Lewis

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
JAMA Oncology|April 26, 2019
Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 TrialQuynh-Nhu Nguyen, Stephen G Chun, Edward Chow, et al.
Annals of Surgical Oncology|February 1, 2023
Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society MembershipRussell G Witt, Rachel K Voss, Yi-Ju Chiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomasPeter W T Pisters, Shreyaskumar R Patel, Victor G Prieto, et al.
Practical Radiation Oncology|January 24, 2026
Outcomes Following Combined Modality Treatment to the Primary Site in Select Patients With Metastatic Soft Tissue SarcomaAndrew J Arifin, Andrew J Bishop, Devarati Mitra, et al.
Cancer Letters|June 7, 2024
BIGH3 mediates apoptosis and gap junction failure in osteocytes during renal cell carcinoma bone metastasis progressionTianhong Pan, Fengshuo Liu, Xiaoxin Hao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2023
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse OutcomesRyan A Denu, Richard K Yang, Alexander J Lazar, et al.
BMJ Supportive & Palliative Care|June 6, 2024
Single-fraction radiation retreatment for bone metastases: role of a rapid access clinicMinsoo Kim, Jose Alberto Maldonado, Prasamsa Pandey, et al.
The Lancet. Oncology|November 7, 2022
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trialB Ashleigh Guadagnolo, Roland L Bassett, Devarati Mitra, et al.
Cancer|August 28, 2024
Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomesAndrew J Bishop, Devarati Mitra, Ahsan Farooqi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
JAMA Oncology|April 26, 2019
Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 TrialQuynh-Nhu Nguyen, Stephen G Chun, Edward Chow, et al.
Annals of Surgical Oncology|February 1, 2023
Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society MembershipRussell G Witt, Rachel K Voss, Yi-Ju Chiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomasPeter W T Pisters, Shreyaskumar R Patel, Victor G Prieto, et al.
Practical Radiation Oncology|January 24, 2026
Outcomes Following Combined Modality Treatment to the Primary Site in Select Patients With Metastatic Soft Tissue SarcomaAndrew J Arifin, Andrew J Bishop, Devarati Mitra, et al.
Cancer Letters|June 7, 2024
BIGH3 mediates apoptosis and gap junction failure in osteocytes during renal cell carcinoma bone metastasis progressionTianhong Pan, Fengshuo Liu, Xiaoxin Hao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2023
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse OutcomesRyan A Denu, Richard K Yang, Alexander J Lazar, et al.
BMJ Supportive & Palliative Care|June 6, 2024
Single-fraction radiation retreatment for bone metastases: role of a rapid access clinicMinsoo Kim, Jose Alberto Maldonado, Prasamsa Pandey, et al.
The Lancet. Oncology|November 7, 2022
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trialB Ashleigh Guadagnolo, Roland L Bassett, Devarati Mitra, et al.
Cancer|August 28, 2024
Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomesAndrew J Bishop, Devarati Mitra, Ahsan Farooqi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, et al.
Pageof 16